NCT06843967 2026-03-13A Study of Mirdametinib in Combination With Palbociclib in People With LiposarcomaMemorial Sloan Kettering Cancer CenterPhase 1/2 Recruiting54 enrolled
NCT04438824 2025-10-14Palbociclib and INCMGA00012 in People With Advanced LiposarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting42 enrolled